Abbott Laboratories Return on Tangible Equity 2010-2024 | ABT
Abbott Laboratories Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2024-03-31 | $5.63B | $7.36B | 97.30% |
2023-12-31 | $5.72B | $6.33B | 114.01% |
2023-09-30 | $5.16B | $5.14B | 118.68% |
2023-06-30 | $5.16B | $4.31B | 137.51% |
2023-03-31 | $5.80B | $4.30B | 177.48% |
2022-12-31 | $6.93B | $3.65B | 307.89% |
2022-09-30 | $7.89B | $2.75B | 583.40% |
2022-06-30 | $8.55B | $2.38B | 4987.76% |
2022-03-31 | $7.73B | $0.23B | -639.62% |
2021-12-31 | $7.07B | $0.05B | -320.21% |
2021-09-30 | $7.24B | $-1.97B | -201.05% |
2021-06-30 | $6.38B | $-3.14B | -131.53% |
2021-03-31 | $5.72B | $-3.78B | -94.14% |
2020-12-31 | $4.50B | $-5.53B | -61.35% |
2020-09-30 | $3.38B | $-6.95B | -41.37% |
2020-06-30 | $3.11B | $-8.07B | -36.33% |
2020-03-31 | $3.58B | $-8.77B | -40.10% |
2019-12-31 | $3.69B | $-8.92B | -39.34% |
2019-09-30 | $3.29B | $-8.49B | -32.88% |
2019-06-30 | $2.90B | $-9.53B | -26.59% |
2019-03-31 | $2.62B | $-10.55B | -22.29% |
2018-12-31 | $2.37B | $-11.47B | -18.92% |
2018-09-30 | $0.89B | $-12.00B | -6.69% |
2018-06-30 | $0.93B | $-13.02B | -7.50% |
2018-03-31 | $0.48B | $-13.57B | -4.20% |
2017-12-31 | $0.48B | $-14.40B | -4.65% |
2017-09-30 | $2.10B | $-8.43B | -46.38% |
2017-06-30 | $1.17B | $-9.00B | -359.48% |
2017-03-31 | $1.50B | $-9.21B | 44.78% |
2016-12-31 | $1.40B | $8.50B | 19.83% |
2016-09-30 | $1.37B | $8.41B | 21.16% |
2016-06-30 | $2.28B | $5.73B | 39.46% |
2016-03-31 | $2.45B | $5.61B | 39.46% |
2015-12-31 | $4.42B | $6.13B | 69.79% |
2015-09-30 | $4.56B | $5.63B | 74.17% |
2015-06-30 | $4.52B | $7.45B | 70.00% |
2015-03-31 | $4.20B | $6.15B | 62.46% |
2014-12-31 | $2.28B | $5.37B | 31.67% |
2014-09-30 | $1.97B | $6.85B | 23.70% |
2014-06-30 | $2.40B | $8.53B | 27.78% |
2014-03-31 | $2.41B | $8.10B | 28.81% |
2013-12-31 | $2.58B | $9.76B | 31.68% |
2013-09-30 | $3.04B | $8.14B | 48.21% |
2013-06-30 | $4.02B | $7.43B | 82.32% |
2013-03-31 | $5.27B | $7.20B | 170.94% |
2012-12-31 | $5.96B | $2.45B | 480.21% |
2012-09-30 | $6.53B | $2.44B | 1938.83% |
2012-06-30 | $4.89B | $0.23B | -571.14% |
2012-03-31 | $5.11B | $-0.15B | -359.46% |
2011-12-31 | $4.73B | $-1.17B | -196.08% |
2011-09-30 | $4.55B | $-2.34B | -131.96% |
2011-06-30 | $5.14B | $-2.03B | -111.53% |
2011-03-31 | $4.49B | $-4.12B | -85.92% |
2010-12-31 | $4.63B | $-5.32B | -86.34% |
2010-09-30 | $4.73B | $-6.97B | -152.11% |
2010-06-30 | $5.31B | $-4.49B | -839.83% |
2010-03-31 | $5.31B | $-4.66B | 579.54% |
2009-12-31 | $5.75B | $3.70B | 267.47% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $181.948B | $40.109B |
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Stryker (SYK) | United States | $126.472B | 30.29 |
Medtronic (MDT) | Ireland | $112.493B | 15.93 |
Boston Scientific (BSX) | United States | $109.225B | 34.79 |
EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
ResMed (RMD) | United States | $32.412B | 30.43 |
Terumo (TRUMY) | Japan | $26.228B | 37.04 |
Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
Baxter (BAX) | United States | $18.054B | 12.84 |
Insulet (PODD) | United States | $12.646B | 56.08 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
Haemonetics (HAE) | United States | $4.900B | 24.24 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
Envista Holdings (NVST) | United States | $3.241B | 13.38 |
QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
Neogen (NEOG) | United States | $2.881B | 27.71 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
ICU Medical (ICUI) | United States | $2.546B | 22.47 |
Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
InMode (INMD) | Israel | $1.583B | 8.42 |
Warby Parker (WRBY) | United States | $1.558B | 0.00 |
Owens & Minor (OMI) | United States | $1.546B | 13.47 |
AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
AtriCure (ATRC) | United States | $1.053B | 0.00 |
Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
Evolus (EOLS) | United States | $0.829B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
Quanterix (QTRX) | United States | $0.684B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
Valneva SE (VALN) | France | $0.616B | 0.00 |
PetIQ (PETQ) | United States | $0.577B | 18.86 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
Surmodics (SRDX) | United States | $0.479B | 29.96 |
ZimVie (ZIMV) | United States | $0.455B | 38.79 |
Biote (BTMD) | United States | $0.435B | 8.33 |
OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
Cerus (CERS) | United States | $0.375B | 0.00 |
Zynex (ZYXI) | United States | $0.350B | 47.87 |
MacroGenics (MGNX) | United States | $0.295B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
Omeros (OMER) | United States | $0.242B | 0.00 |
Veru (VERU) | United States | $0.215B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
High Tide (HITI) | Canada | $0.190B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
InterCure (INCR) | Israel | $0.149B | 25.23 |
Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.84 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
MariMed (MRMD) | United States | $0.095B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
Brainsway (BWAY) | Israel | $0.090B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
Safety Shot (SHOT) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.042B | 15.37 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Sharps Technology (STSS) | United States | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |